GENERATIXE
Live / Allowed — Second extension granted (statement of use) (as of 14 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Apr 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98522751
- Mark type
- Word mark
- Filed
- 27 Apr 2024
- Published for opposition
- 10 Dec 2024
Goods and services
- Class 042 — Scientific and technological services: Biochemical research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Circular RNA vaccine research; Gene therapy research; Pharmaceutical research and development; Pharmaceutical research services; RNA interference technology research; Scientific research; Scientific research and development
Owner
- Generatixe Inc., San Diego, CA, US
- Generatixe Inc., Austin, TX, US
Board proceedings on this mark
- Extension of Time to Oppose No. 98522751 — Generate Biomedicines, Inc. v. Generatixe Inc., filed 02 Jan 2025 (Terminated)
Prosecution history
- 15 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Aug 2026 — SOU EXTENSION 2 GRANTED
- 23 May 2026 — SOU EXTENSION 2 FILED
- 13 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 May 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Aug 2025 — SOU EXTENSION 1 GRANTED
- 16 Aug 2025 — SOU EXTENSION 1 FILED
- 16 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Apr 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 02 Jan 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED